EDITORIAL SECTION

Articles

How Pharma 4.0 Is Revolutionizing Drug Manufacturing

The pharmaceutical industry in the world is experiencing a digital transformation rejuvenated by the advent of Pharma an industry phenomenon that is based on Industry Due to the readjustment of the manufacturing industry to Industry the automation data interchange and intelligent ecosystem the pharmaceutical ecosystem is similarly being reorganized with Pharma technologies Research and develo...

Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics

People respond very differently to medications depending on their weight age inborn capability to metabolize drugs the individual characteristics of the disease or the presence of comorbidities The wellknown assumption that one size fits all has clearly revealed all its limitations and become questionable Notably among humans pediatric patients represent

Exploring the Benefits of Sustainable Clinical Trials

The landscape of clinical trials is evolving with a growing recognition that research endeavors should extend beyond scientific excellence to encompass broader societal environmental and economic considerations

Role of Artificial Intelligence in Pharmaceutical Industry

The global AI in the pharma market expanded to a size of nearly million in The market is anticipated to increase at a rate of from million in to million in Researchers claim that the application of these technologies enhances decisionmaking maximizes creativity increases the effectiveness of research and clinical trials

Bispecific Antibodies: Transforming the Future of Oncology

For two decades bispecific antibodies occupied an awkward position in pharmaceutical oncology strategy scientifically compelling commercially unproven and persistently difficult to manufacture That characterisation no longer holds Nineteen bispecific antibodies have been approved globally and combined sales of the class passed twelve billion dollars in with several products now anchoring

Patient-Centric Clinical Trials: Improving Recruitment, Retention, and Diversity

Patientcentricity has spent a decade as a value statement in pharmaceutical annual reports and comparatively little time as an operating discipline That gap is now closing not because the argument became more persuasive but because the economics and the regulatory environment stopped tolerating the alternative

Techno Trends

University of Dundee’s Cabamiquine Shows Promise for Single-Dose Malaria Treatment

Researchers at the University of Dundee have reported encouraging clinical results for cabamiquine a novel antimalarial compound being developed as a potential singledose treatment for malaria

Projects

Genentech to Invest US$750 Million in Oregon Device Fill-Finish Facility

Genentech a member of the Roche Group plans to invest approximately US million in a new device fillfinish manufacturing facility at its acre campus in Hillsboro Oregon The project will add endtoend manufacturing

Research Insights

One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases

Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys